Clinical Trials Browser

Phase 2 × Terminated × taxane × Clear all

NCT04364048 2024-12-20

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Phase 2 Terminated

10 enrolled 10 charts

Lung Neoplasms

NCT00359450 2010-03-02

Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung